MetLife (NYSE:MET) PT Raised to $86.00

→ The biggest energy story ever? (From Porter & Company) (Ad)

MetLife (NYSE:MET - Get Free Report) had its target price lifted by stock analysts at Wells Fargo & Company from $83.00 to $86.00 in a research report issued on Thursday, Benzinga reports. The firm currently has an "overweight" rating on the financial services provider's stock. Wells Fargo & Company's target price points to a potential upside of 21.18% from the company's current price.

A number of other equities analysts have also commented on MET. UBS Group dropped their price target on MetLife from $87.00 to $82.00 and set a "buy" rating for the company in a research note on Monday, February 5th. Piper Sandler upped their price objective on MetLife from $74.00 to $85.00 and gave the company an "overweight" rating in a research report on Friday, April 5th. The Goldman Sachs Group upgraded MetLife from a "neutral" rating to a "buy" rating and upped their price objective for the company from $70.00 to $80.00 in a research report on Monday, January 8th. Finally, Keefe, Bruyette & Woods upped their price objective on MetLife from $82.00 to $87.00 and gave the company an "outperform" rating in a research report on Wednesday. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $79.08.


View Our Latest Research Report on MET

MetLife Price Performance

MetLife stock traded down $0.94 during midday trading on Thursday, reaching $70.97. 4,251,768 shares of the stock traded hands, compared to its average volume of 3,614,225. The stock's fifty day moving average is $70.62 and its 200-day moving average is $66.46. MetLife has a 12 month low of $48.95 and a 12 month high of $74.68. The stock has a market cap of $51.31 billion, a P/E ratio of 38.63, a PEG ratio of 0.56 and a beta of 1.04. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.53.

MetLife (NYSE:MET - Get Free Report) last announced its quarterly earnings results on Wednesday, January 31st. The financial services provider reported $1.93 EPS for the quarter, missing analysts' consensus estimates of $1.95 by ($0.02). MetLife had a net margin of 2.36% and a return on equity of 19.48%. The firm had revenue of $18.72 billion for the quarter, compared to the consensus estimate of $18.07 billion. As a group, equities research analysts anticipate that MetLife will post 8.73 EPS for the current year.

Insider Transactions at MetLife

In other news, EVP Bill Pappas sold 27,000 shares of the stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $72.27, for a total value of $1,951,290.00. Following the sale, the executive vice president now directly owns 57,768 shares in the company, valued at $4,174,893.36. The sale was disclosed in a document filed with the SEC, which is available at this link. In other MetLife news, insider Ramy Tadros sold 4,026 shares of the stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total transaction of $289,469.40. Following the sale, the insider now owns 146,981 shares of the company's stock, valued at approximately $10,567,933.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Bill Pappas sold 27,000 shares of the stock in a transaction on Monday, March 18th. The shares were sold at an average price of $72.27, for a total value of $1,951,290.00. Following the sale, the executive vice president now directly owns 57,768 shares in the company, valued at approximately $4,174,893.36. The disclosure for this sale can be found here. Company insiders own 0.32% of the company's stock.

Institutional Trading of MetLife

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. IHT Wealth Management LLC boosted its position in shares of MetLife by 4.5% in the 4th quarter. IHT Wealth Management LLC now owns 3,466 shares of the financial services provider's stock worth $251,000 after purchasing an additional 150 shares in the last quarter. Marcum Wealth LLC boosted its position in shares of MetLife by 4.7% in the 1st quarter. Marcum Wealth LLC now owns 3,436 shares of the financial services provider's stock worth $255,000 after purchasing an additional 153 shares in the last quarter. Carolinas Wealth Consulting LLC boosted its position in shares of MetLife by 26.4% in the 1st quarter. Carolinas Wealth Consulting LLC now owns 767 shares of the financial services provider's stock worth $54,000 after purchasing an additional 160 shares in the last quarter. Harbour Investments Inc. boosted its position in shares of MetLife by 3.2% in the 4th quarter. Harbour Investments Inc. now owns 5,269 shares of the financial services provider's stock worth $381,000 after purchasing an additional 162 shares in the last quarter. Finally, Great Valley Advisor Group Inc. boosted its position in shares of MetLife by 1.9% in the 4th quarter. Great Valley Advisor Group Inc. now owns 8,898 shares of the financial services provider's stock worth $588,000 after purchasing an additional 167 shares in the last quarter. Institutional investors own 89.81% of the company's stock.

MetLife Company Profile

(Get Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Analyst Recommendations for MetLife (NYSE:MET)

Should you invest $1,000 in MetLife right now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: